Statistical significance in a such a small study group is a big deal. I’m with WAG, I don’t give a hoot what the share price does today. Look forward to the webinar.
Big pharma are going to have to ante up!
Now for a bex and a quick lie down. Not gonna lie, Im getting to old for these heart stopping moments.
Enjoy the day all.
Ann: Phase 2 trial shows significant improvements in Angelman, page-24
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.18 |
Change
-0.475(3.48%) |
Mkt cap ! $1.696B | |||
| Open | High | Low | Value | Volume |
| $13.68 | $13.68 | $13.12 | $2.707M | 202.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $13.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.19 | 117 | 3 |
View Market Depth
| Last trade - 15.02pm 18/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |